125 related articles for article (PubMed ID: 9192780)
21. Fc and complement receptor (CR1 and CR3) expression on neonatal human polymorphonuclear leukocytes.
Fleit HB
Biol Neonate; 1989; 55(3):156-63. PubMed ID: 2525933
[TBL] [Abstract][Full Text] [Related]
22. The roles of complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) in the regulation of the immune complex-elicited respiratory burst of polymorphonuclear leukocytes in whole blood.
Nielsen CH; Antonsen S; Matthiesen SH; Leslie RG
Eur J Immunol; 1997 Nov; 27(11):2914-9. PubMed ID: 9394818
[TBL] [Abstract][Full Text] [Related]
23. Characterization of rat complement receptors and regulatory proteins. CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1.
Quigg RJ; Holers VM
J Immunol; 1995 Aug; 155(3):1481-8. PubMed ID: 7636211
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of complement receptor type 1 from rat glomerular epithelial cells.
Quigg RJ; Galishoff ML; Sneed AE; Kim D
Kidney Int; 1993 Mar; 43(3):730-6. PubMed ID: 8455373
[TBL] [Abstract][Full Text] [Related]
25. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.
Reynes M; Aubert JP; Cohen JH; Audouin J; Tricottet V; Diebold J; Kazatchkine MD
J Immunol; 1985 Oct; 135(4):2687-94. PubMed ID: 2411809
[TBL] [Abstract][Full Text] [Related]
26. Internalization of type 1 complement receptors and de novo multivesicular body formation during chemoattractant-induced endocytosis in human neutrophils.
Berger M; Wetzler E; August JT; Tartakoff AM
J Clin Invest; 1994 Sep; 94(3):1113-25. PubMed ID: 8083352
[TBL] [Abstract][Full Text] [Related]
27. Expression of the complement receptors CR1 and CR3 and the type III Fc gamma receptor on neutrophils from newborn infants and from fetuses with Rh disease.
Smith JB; Campbell DE; Ludomirsky A; Polin RA; Douglas SD; Garty BZ; Harris MC
Pediatr Res; 1990 Aug; 28(2):120-6. PubMed ID: 2144335
[TBL] [Abstract][Full Text] [Related]
28. Calcium requirements for increased complement receptor expression during neutrophil activation.
Berger M; Birx DL; Wetzler EM; O'Shea JJ; Brown EJ; Cross AS
J Immunol; 1985 Aug; 135(2):1342-8. PubMed ID: 3159792
[TBL] [Abstract][Full Text] [Related]
29. The mechanism of loss of CR1 during maturation of erythrocytes is different between factor I deficient patients and healthy donors.
Miot S; Marfurt J; Lach-Trifilieff E; González-Rubio C; López-Trascasa M; Sadallah S; Schifferli JA
Blood Cells Mol Dis; 2002; 29(2):200-12. PubMed ID: 12490287
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes.
Voice JK; Lachmann PJ
Eur J Immunol; 1997 Oct; 27(10):2514-23. PubMed ID: 9368604
[TBL] [Abstract][Full Text] [Related]
31. Intracellular pools of FcalphaR (CD89) in human neutrophils are localized in tertiary granules and secretory vesicles, and two FcalphaR isoforms are found in tertiary granules.
Yin N; Peng M; Xing Y; Zhang W
J Leukoc Biol; 2007 Sep; 82(3):551-8. PubMed ID: 17576823
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil tissue inhibitor of matrix metalloproteinases-1 occurs in novel vesicles that do not fuse with the phagosome.
Price B; Dennison C; Tschesche H; Elliott E
J Biol Chem; 2000 Sep; 275(36):28308-15. PubMed ID: 10869345
[TBL] [Abstract][Full Text] [Related]
33. Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase.
Borregaard N; Christensen L; Bejerrum OW; Birgens HS; Clemmensen I
J Clin Invest; 1990 Feb; 85(2):408-16. PubMed ID: 2298916
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil activation during transmigration in vivo and in vitro A translational study using the skin chamber model.
Paulsson JM; Jacobson SH; Lundahl J
J Immunol Methods; 2010 Sep; 361(1-2):82-8. PubMed ID: 20691696
[TBL] [Abstract][Full Text] [Related]
35. Receptors for C3b on the neutrophil surface associate with the cytoskeleton-containing cell residue subsequent to cell lysis with non-ionic detergent. Cytoskeletal-CR1 interactions.
Katz JD; Rimmerman CM; Berrettoni BA; Hafeman DG
J Immunol Methods; 1987 May; 99(1):83-93. PubMed ID: 2952734
[TBL] [Abstract][Full Text] [Related]
36. Localization of Fc gamma receptors and complement receptors CR1 on human peripheral nerve fibres by immunoelectron microscopy.
Vedeler CA; Nilsen R; Matre R
J Neuroimmunol; 1989 Jun; 23(1):29-33. PubMed ID: 2470779
[TBL] [Abstract][Full Text] [Related]
37. Intracellular degradation of the complement C3b/C4b receptor in the absence of ligand.
Turner JR; Tartakoff AM; Berger M
J Biol Chem; 1988 Apr; 263(10):4914-20. PubMed ID: 2965151
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
Fischer E; Appay MD; Cook J; Kazatchkine MD
J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
[TBL] [Abstract][Full Text] [Related]
39. The influence of antibody functional affinity on the effector functions involved in the clearance of circulating immune complexes anti-BSA IgG/BSA.
Marzocchi-Machado CM; Polizello AC; Azzolini AE; Lucisano-Valim YM
Immunol Invest; 1999; 28(2-3):89-101. PubMed ID: 10484684
[TBL] [Abstract][Full Text] [Related]
40. Granulocyte-macrophage colony-stimulating factor increases synthesis and expression of CR1 and CR3 by human peripheral blood neutrophils.
Neuman E; Huleatt JW; Jack RM
J Immunol; 1990 Nov; 145(10):3325-32. PubMed ID: 1977799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
